Navigation Links
AtheroGenics Reports ARISE Trial Results for AGI-1067

Full Study Results to Be Presented at the American College of Cardiology's Scientific Session

WIRE) -- 03/19/2007 -- AtheroGenics, Inc. (NASDAQ: AGIX) today announced that its ARISE Phase III clinical study of its lead drug candidate, AGI-1067, did not show a difference from placebo in its composite primary endpoint; however, it did achieve a number of other important predefined endpoints. These endpoints included a reduction in the composite of "hard" atherosclerotic clinical endpoints, composed of cardiovascular death, myocardial infarction (heart attack) and stroke, as well as an improvement in several key diabetes parameters, including glycemic control.

A full description of the ARISE study results will be presented by the ARISE principal investigators, Jean-Claude Tardif, M.D., Director of Research; Professor of Medicine, Montreal Heart Institute; and Marc Pfeffer, M.D., Ph.D., Professor of Medicine, Harvard Medical School; Senior Physician in Cardiology at Brigham and Women's Hospital, at the Late Breaking Clinical Trials session (Room Hall A) at the American College of Cardiology (ACC) Scientific Session in New Orleans on Tuesday, March 27 at 9:35 a.m. CDT.

While the company is disappointed that the composite primary endpoint was not met, it is encouraged by the positive results demonstrated in a number of disease states. As a result of the review of this data, the company has determined that the further development of AGI-1067 is important and the company currently intends to continue to pursue opportunities for development. The company will continue to review the data of the clinical study to prepare for discussions with the FDA to evaluate development paths forward for the drug.

A preliminary analysis of the safety data indicated th
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AtheroGenics Reports ARISE Trial Results for AGI
(Date:12/15/2009)... Ill., Dec. 15 Fenwal Inc., a ... collection, separation, safety and availability, announced today that ... Fenwal approval to market InterSol ® platelet ... solution is a specialized product used in ... a vital blood component used to prevent or ...
(Date:12/15/2009)... -- ,, Reportlinker.com announces that a new ... catalogue: ,, Hepatitis B Vaccines - ... ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, Hepatitis ... Forecasts to 2015 ,, Summary ... report, "Hepatitis B Vaccines - Pipeline Analysis ...
(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, http://www.reportlinker.com/p0168192/Top-Ten-Worlds-Leading-Orthopedics-Companies.html ... the competitive environment is unquestionably one ... the task crucial to business survival, ... competitive intelligence is vital to the ...
Breaking Medicine Technology:Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Top Ten World's Leading Orthopedics Companies 2Reportlinker Adds Top Ten World's Leading Orthopedics Companies 3Satellite Dialysis Opens New Center in San Leandro CA 61499 1Satellite Dialysis Opens New Center in San Leandro CA 61499 2Vivakor Inc Announces Stock Dividend 14870 1Vivakor Inc Announces Stock Dividend 14870 2Vivakor Inc Announces Stock Dividend 14870 3Vivakor Inc Announces Stock Dividend 14870 4Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM 28R 29 Kit is a Reliable Rapid Method for Extrac 14868 1Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM 28R 29 Kit is a Reliable Rapid Method for Extrac 14868 2Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM 28R 29 Kit is a Reliable Rapid Method for Extrac 14868 3Forensic Scientists at Kansas City Crime Lab Release Validation Report Confirming Zygems forensicGEM 28R 29 Kit is a Reliable Rapid Method for Extrac 14868 4
... be placed in the brain to treat a stroke as ... Annual International Symposium on Endovascular Therapy (ISET).Stents have long been ... to prevent heart attacks and in the neck to prevent ... to treat occurring heart attacks by opening up the blocked ...
... the international,investment house specialising in medical sciences, said ... pioneering stem cell treatments if it is,to remain ... Professor Sir Christopher Evans, founder ... plc has received approval from the UK,Medicines and ...
Other Medicine Technology:Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research 2Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research 3UK Must Maintain its Momentum in Stem Cell Expertise 2
(Date:12/15/2009)... Dec. 15 Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged ... today announced that shareholders had approved all three resolutions that the Company had proposed at ... follows: , , Description of ... Votes ... For ...
(Date:12/15/2009)... SUNNYVALE, Calif., Dec. 15 Palo Alto ... Shinshu University has deployed its PA-4000 Series next-generation ... network and for enhanced visibility and control over ... University is a Japanese national university with eight ... in 1949 by integrating a number of academic ...
(Date:12/15/2009)... Proceeds will be donated to the Lupus Foundation of ... ,, WASHINGTON, Dec. 15 Julian Lennon, son ... today released their new digital single, "LUCY," to raise ... until March 15, 2010, 100 percent of the proceeds ... the Lupus Foundation of America (LFA), and the Saint ...
(Date:12/15/2009)... Dec. 15 Vitech Systems Group, a ... Management (CRM) software, announced today that it has ... for the Screen Actors Guild-Producers Pension & Health ... customer service capabilities to SAG-PH call center personnel ... was installed using Vitech,s V3 Benefits Administration System ...
(Date:12/15/2009)... levels of leptin associated with lower dementia risk, research ... blood levels of leptin, a hormone that regulates appetite, ... "Hopefully, in 10 or 15 years this may be ... the risk of Alzheimer,s disease," said senior study author ... Boston University School of Medicine. "Or it may be ...
Breaking Medicine News(10 mins):Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3
... therapy should be , , FRIDAY, May 15 (HealthDay ... to better customize the treatment of prostate cancer. , ... men could survive with metastatic prostate cancer have been ... who say such information would help doctors individualize treatments. ...
... CDC says confirmed cases, including 2 new deaths, may not ... 16 (HealthDay News) -- While the official tally of confirmed ... the Centers for Disease Control and Prevention now estimate the ... Also on Friday, health officials announced two new deaths linked ...
... Find the Solutions to their Infertility Issues by Bridging the Gap ... ... (PRWEB) May 16, 2009 -- National Fertility Link ... be pregnant. National Fertility Link helps Infertile couples find the best ...
... emergency department is overcrowded with seriously sick and injured ... other emergency departments. But the benefits of "diversion" are ... crowded, and the greater distance to that other hospital ... 2006, a group of teaching hospitals in Boston agreed ...
... of these developments, The Villa Group encourages travelers to ... Mexico now. CDC today removed the Travel Health ... for travel health safety. SAN DIEGO, May 15 ... H1N1 virus in Mexico, CDC has noted that the ...
... resume visits to Mexican ports of call based on ... which is no longer recommending against non-essential travel to ... completed, those vessels will revert to their original routes ... through mid-June with the exception of the Holiday which ...
Other Medicine News:Health News:An Aid to Tailoring Prostate Cancer Treatment 2Health News:Swine Flu May Have Infected More Than 100,000 Americans 2Health News:Swine Flu May Have Infected More Than 100,000 Americans 3Health News:Swine Flu May Have Infected More Than 100,000 Americans 4Health News:Swine Flu May Have Infected More Than 100,000 Americans 5Health News:Swine Flu May Have Infected More Than 100,000 Americans 6Health News:Swine Flu May Have Infected More Than 100,000 Americans 7Health News:Swine Flu May Have Infected More Than 100,000 Americans 8Health News:Swine Flu May Have Infected More Than 100,000 Americans 9Health News:Swine Flu May Have Infected More Than 100,000 Americans 10Health News:Swine Flu May Have Infected More Than 100,000 Americans 11Health News:Swine Flu May Have Infected More Than 100,000 Americans 12Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 2Health News:Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics 3Health News:Centers for Disease Control Lifts Travel Health Warning for Mexico 2Health News:Carnival Cruise Lines to Resume Port Calls in Mexico 2
"Small" redefined for Holter recorders!...
The MYO-VAD is a novel cardiac support system with unique, life-saving features....
LOGIQ Book XP provides you the next generation performance in a compact platform....
The Rio Catheter is designed to simplify your intravascular interventions by removing thrombus and restoring epicardial flow to the procedure....
Medicine Products: